Research Funding

  • February 1, 1999 - March 31, 2014 - Basic Research in Hematology and Oncology, Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: T32DK007636
  • August 5, 1999 - September 29, 2012 - Cancer Center Support Grant, Co-Investigator. Sponsor: NIH/NCI, Sponsor Award ID: P30CA082103
  • September 25, 2000 - June 30, 2010 - UCSF PROSTATE CANCER SPORE, Co-Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: P50CA089520
  • February 1, 1996 - December 31, 2006 - TRANSFUSION BIOLOGY AND MEDICINE, Co-Principal Investigator. Sponsor: NIH/NHLBI, Sponsor Award ID: P50HL054476

Education

University of Wisconsin, Madison Madison, WI, B.S., 1962, Philosophy/Chemistry
University of PA, Philadelphia Philadelphia, PA, Biology
Thomas Jefferson Medical College Philadelphia, PA, M.D., 1967, Medicine

Honors & Awards

  • 1980
    Elected to American Society of Clinical Investigation
  • 1981
    Awarded Research Career Development Award, National Institutes of Health
  • 1989
    Elected to Association of American Physicians

Selected Publications

  1. Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.  View on PubMed
  2. Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.  View on PubMed
  3. Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.  View on PubMed
  4. Ge F, Wang DD, Li L, Lin PP, Shuman MA WITHDRAWN: Enhanced Detection and Phenotypic and Karyotypic in Situ Characterization of Circulating Tumor Cells.  View on PubMed
  5. Kadoch C, Li J, Wong VS, Chen L, Cha S, Munster P, Lowell CA, Shuman MA, Rubenstein JL Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.  View on PubMed
  6. Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E, Batchelor T, Krouwer H, Hwang J, Auerback G, Kadoch C, Lowell C, Munster P, Cha S, Shuman MA, Damon LE Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.  View on PubMed
  7. Huang X, Dubuc AM, Hashizume R, Berg J, He Y, Wang J, Chiang C, Cooper MK, Northcott PA, Taylor MD, Barnes MJ, Tihan T, Chen J, Hackett CS, Weiss WA, James CD, Rowitch DH, Shuman MA, Jan YN, Jan LY Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.  View on PubMed
  8. Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.  View on PubMed
  9. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC Upregulation of Cyclin B1 by miRNA and its implications in cancer.  View on PubMed
  10. Sun C, Su KH, Valentine J, Rosa-Bauza YT, Ellman JA, Elboudwarej O, Mukherjee B, Craik CS, Shuman MA, Chen FF, Zhang X Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors.  View on PubMed
  11. So AY, de la Fuente E, Walter P, Shuman M, Bernales S The unfolded protein response during prostate cancer development.  View on PubMed
  12. Kadoch C, Dinca EB, Voicu R, Chen L, Nguyen D, Parikh S, Karrim J, Shuman MA, Lowell CA, Treseler PA, James CD, Rubenstein JL Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.  View on PubMed
  13. Rubenstein JL, Shen A, Batchelor TT, Kadoch C, Treseler P, Shuman MA Differential gene expression in central nervous system lymphoma.  View on PubMed
  14. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL Protein biomarker identification in the CSF of patients with CNS lymphoma.  View on PubMed
  15. Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.  View on PubMed
  16. Chan JM, Feraco A, Shuman M, Hernández-Díaz S The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.  View on PubMed
  17. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M Gene expression and angiotropism in primary CNS lymphoma.  View on PubMed
  18. Tindall D, Horne FM, Hruszkewycz A, Mohla S, Shuman M, Wang Z, Kantoff P Symposium on androgen action in prostate cancer.  View on PubMed
  19. Reddy JC, Shuman MA, Aster RH Quinine/quinidine-induced thrombocytopenia: a great imitator.  View on PubMed
  20. Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.  View on PubMed

Go to UCSF Profiles, powered by CTSI